Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2025-12-25 @ 10:32 PM
Study NCT ID:
NCT00408967
Status:
WITHDRAWN
Last Update Posted:
2017-08-18
First Post:
2006-12-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.
Sponsor:
EMD Serono
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12-31
Start Date Type:
ACTUAL
Primary Completion Date:
2008-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-06
First Submit QC Date:
None
Study First Post Date:
2006-12-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-15
Last Update Post Date:
2017-08-18
Last Update Post Date Type:
ACTUAL